Home
eXmoor Pharma

eXmoor Pharma Market Share Analysis for June 2026

Drew Hope, our Senior Compliance Consultant and UK QP, shares his insights on the regulatory and technical challenges surrounding induced pluripotent stem cell (iPSC) therapy development, and why early CMC strategy is critical.

Industry: N/A

Domainexmoorpharma.com

Year Founded2004

Employees51 - 200

Annual Revenue$5M - $10M

eXmoor Pharma

eXmoor Pharma (including company regionals)

exmoorpharma.com

See more website traffic and engagement information

eXmoor Pharma Revenue up to June 2026 is 5M - 10M

revenue generated by eXmoor Pharma top domains

eXmoor Pharma top domains revenue over 3 years

Revenue for eXmoor Pharma top domains

exmoorpharma.com5M - 10M

See more with Sales Intelligence

Total visits to eXmoor Pharma's top domains

Understand eXmoor Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

exmoorpharma.com2.1K

See more with Sales Intelligence

Avg. visit duration in eXmoor Pharma's top domains

Analyze eXmoor Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

exmoorpharma.com00:00:01

See more with Sales Intelligence

Avg. pageviews on eXmoor Pharma's top domains

See how eXmoor Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

exmoorpharma.com1.34

See more with Sales Intelligence

eXmoor Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by eXmoor Pharma

These are the website technologies, by industry, used by eXmoor Pharma top domains

Widget (8)

Twemoji

Advertising (4)

Google Adsense

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from eXmoor Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewseXmoor Pharma Concepts Ltd partnered with Evox Therapeutics Ltd. on Jul 21st '26.Bristol, UK - 21 July 2026: eXmoor Pharma ('eXmoor'), the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Evox Therapeutics ('Evox') have completed a technology transfer programme for Evox's exosome-enabled gene editing technology and specifically its MSH3-targeted programme for the treatment of Huntington's disease.

NewseXmoor Pharma Concepts Ltd promotes Emma Ewins to fractional Chief Technology Officer.eXmoor Pharma has announced two leadership appointments, with Emma Ewins promoted to Chief Operating Officer and Dr James Miskin taking on an expanded role as fractional Chief Technology Officer.

NewsSignadori Bio, SAS partners with eXmoor Pharma Concepts Ltd.Signadori has also entered a development collaboration with eXmoor Pharma, a UK-based cell and gene therapy CDMO, to support the transition toward GMP-compliant manufacturing for SiB-2101.